QZQiang Zhang

Qiang Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Qiang Zhang has a total of 19 co-authors. Here are the top co-authors by number of shared publications:

  • Guanghui Wei

    Department of Urology Children's Hospital of Chongqing Medical University Chongqing China

    4 shared publications
  • Xing Liu

    Department of Urology, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Children’s Hospital of Chongqing Medical University, Chongqing, People’s Republic of China

    4 shared publications
  • Zhicheng Zhang

    Department of Urology Children's Hospital of Chongqing Medical University Chongqing China

    4 shared publications
  • Hongsong Chen

    Department of Urology Children's Hospital of Chongqing Medical University Chongqing China

    3 shared publications
  • Xingguo Luo

    Department of Urology Children's Hospital of Chongqing Medical University Chongqing China

    3 shared publications
  • Chunlan Long

    Department of Urology Children's Hospital of Chongqing Medical University National Clinical Research Center for Children and Adolescents' Health and Diseases Ministry of Education Key Laboratory of Child Development and Disorders Chongqing China

    2 shared publications

Latest Publications

  • A stent‐plus‐irrigation protocol after adolescent hypospadias repair: a multicentre randomised controlled trial

    by Zihan Ye, Hongsong Chen, Qiang Zhang, Xingguo Luo, Zhicheng Zhang, Guanghui Wei, Li Zeng, Ning Li, Gaofeng Zhang, Wei Liu, et al.

    Objectives: To evaluate whether a stent‐plus‐irrigation protocol reduces complication rates following hypospadias repair in adolescents compared with catheter drainage alone. Patients and Methods: In this multicentre randomised controlled trial, adolescents (Tanner Stage II–V) undergoing hypospadias repair were randomly assigned to either a stent‐plus‐irrigation group or a catheter‐drainage group. The catheter‐drainage group received standard urethral catheter drainage alone, whereas the stent‐plus‐irrigation group received an additional small‐calibre urethral stent positioned within the reconstructed urethra and twice‐daily saline irrigation. The primary outcome was the overall postoperative complication rate; secondary outcomes included urinary function and cosmetic outcomes. Results: A total of 172 adolescents were assessed for eligibility, with 150 participants (75 in the stent‐plus‐irrigation group and 75 in the catheter‐drainage group) included in the final analysis. Compared with the catheter‐drainage group, the stent‐plus‐irrigation group demonstrated a significantly lower overall complication rate (risk ratio [RR] 0.33, 95% confidence interval [CI] 0.20–0.56; P < 0.001), urethral fistula rate (RR 0.27, 95% CI 0.14–0.51; P < 0.001), and surgical site infection (SSI) rate (RR 0.43, 95% CI 0.21–0.87; P = 0.020). Conclusions: A postoperative stent‐plus‐irrigation protocol was associated with lower rates of postoperative complications, particularly urethral fistula and SSI, compared with catheter drainage alone after adolescent hypospadias repair. Because the intervention included both an additional urethral stent and saline irrigation, the independent contribution of irrigation cannot be determined in this two‐arm trial.

  • Open Access

    MicroRNA‐130a‐3p Targets the Androgen‐Related Transcription Factor MAFB : Effects on Proliferation, Migration, Apoptosis, and Cell Cycle in Hypospadias

    by Jiaxin Zhou, Yixuan Wang, Zhicheng Zhang, Qiang Zhang, Zhenmin Liu, Hongsong Chen, Xingguo Luo, Chunlan Long, Lianju Shen, Xing Liu, et al.

    Hypospadias is among the most frequent congenital malformations of the male genitalia. The expression of V‐maf musculoaponeurotic fibrosarcoma oncogene homolog B ( MAFB ), a transcription factor within the androgen signaling pathway, is closely correlated with the etiology of this condition. From an epigenetic perspective, this study investigated the role of microRNA‐130a‐3p (miR‐130a‐3p) in regulating MAFB during hypospadias pathogenesis. Clinical foreskin samples from hypospadias children and the dioctyl phthalate (DEHP)‐induced mouse genital tubercle tissues were analyzed. The expression levels of miR‐130a‐3p and MAFB were detected by qRT‐PCR and western blot. In vitro, miR‐130a‐3p was modulated in HS68 cells; CCK‐8, scratch assay, western blot, flow cytometry, and dual‐luciferase assay were used to assess its effects and targeting of MAFB . Our study demonstrated that miR‐130a‐3p targeted and suppressed MAFB expression. This suppression inhibited cellular proliferation and migration and reduced Vimentin mRNA expression. Cell cycle distribution was disrupted, marked by Gap 1 phase increase and Synthesis phase reduction, and the cell apoptosis rate increased. Cyclin‐dependent kinase 2 (CDK2), Cyclin E1, and Proliferating Cell Nuclear Antigen (PCNA) were downregulated. miR‐130a‐3p targets and inhibits MAFB expression, disrupting the normal processes of cell proliferation, migration, cell apoptosis, and cell cycle progression, ultimately leading to the development of hypospadias.

  • Association Between Vitamin D Status and Nocturnal Lower Urinary Tract Symptoms: A Pooled Analysis

    by Zihan Ye, Hongsong Chen, Qiang Zhang, Xingguo Luo, Chang Li, Zhicheng Zhang, Guanghui Wei, Xing Liu

    Context: Cumulative evidence suggests an association between vitamin D and nocturnal lower urinary tract symptoms (nLUTS), but results remain inconclusive. Objective: To systematically assess the relationship between vitamin D status or intake and nLUTS via a systematic review and meta-analysis. Data Sources: The PubMed, Scopus, Embase, and Web of Science databases were searched through July 2025 without language restrictions. Case-control, cross-sectional, cohort, and randomized controlled trials (RCTs) evaluating the effects of vitamin D status or intake on nLUTS were included. Data Extraction: A total of 2725 articles were identified through the literature search, of which 17 met the inclusion criteria for the systematic review. These comprised 5 RCTs, 2 cohort studies, 4 cross-sectional studies, and 6 case-control studies. Data Analysis: Vitamin D deficiency (<20 ng mL–1) was associated with a 4.86-fold increase in the odds of nLUTS, and mean serum 25-hydroxyvitamin D levels were 7.75 ng mL–1 lower in individuals with nLUTS than in control participants. Vitamin D supplementation correlated with an 86% relative risk reduction for nLUTS and a decrease of 0.23 nocturnal voids per night. Stronger associations were observed in pediatric populations and patients with nocturnal polyuria. Conclusions: Vitamin D deficiency is a significant risk factor for nLUTS; supplementation may offer therapeutic benefits. Assessing vitamin D status could guide nLUTS management. Systematic Review Registration: PROSPERO registration no. CRD420251004940.

  • Vitamin D levels and the risk of overactive bladder: a systematic review and meta-analysis

    by Qiang Zhang, Zhicheng Zhang, Xueyu He, Zhenmin Liu, Lianju Shen, Chunlan Long, Guanghui Wei, Xing Liu, Chunming Guo

    Context: Overactive bladder is treated mainly with behavioral and drug therapy, and symptoms of urinary frequency and incontinence are challenging to eliminate. There is thus a continuous unmet need for new drugs with a substitution effect mechanism. Objective: It not known whether vitamin D deficiency can lead to overactive bladder or urinary incontinence or whether vitamin D supplementation alleviates bladder symptoms. This comprehensive systematic review with meta-analysis was conducted to determine whether overactive bladder is associated with vitamin D deficiency. Data Sources: The PubMed and Cochrane Library databases were searched systematically up to July 3, 2022. Data Extraction: Initially, 706 articles were identified in the literature search, of which 13 were included in the systematic review: 4 randomized controlled trials, 3 cohort studies, 3 cross-sectional studies, and 3 case-control studies. Data Analysis: An increased risk of overactive bladder and urinary incontinence was observed with vitamin D deficiency (odds ratio [OR] = 4.46; 95%CI, 1.03–19.33; P = 0.046 and OR = 1.30; 95%CI, 1.01–1.66; P = 0.036, respectively). Vitamin D levels were relatively low in patients with overactive bladder or urinary incontinence (SMD = −0.33; 95%CI, −0.61 to −0.06, P = 0.019). On the basis of existing data, the risk of urinary incontinence was reduced by 66% after vitamin D supplementation (OR = 0.34; 95%CI, 0.18–0.66; P = 0.001). Egger test was conducted to assess publication bias, and the results were tested for robustness using a sensitivity analysis. Conclusions: Vitamin D deficiency increases the risk of overactive bladder and urinary incontinence, and vitamin D supplementation reduces the risk of urinary incontinence. The development of new strategies to prevent or alleviate bladder symptoms is crucial. Vitamin D supplementation may be gaining recognition as an effective strategy for prevention or alleviation of bladder symptoms such as overactive bladder and incontinence. Systematic Review Registration: PROSPERO registration no. CRD42022351443.